 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 December 1994 | Volume 121 Issue 12 | Pages 947-952
Objective: To estimate the cost-effectiveness and net medical care costs of programs for annual influenza vaccinations for the elderly in a health maintenance organization (HMO).
Design: Population-based, case–control study.
Setting: The Northwest Region of Kaiser Permanente, a prepaid group practice HMO in Portland, Oregon.
Participants: Kaiser Permanente members 65 years of age and older who had at least 1 month of HMO eligibility during any of nine influenza seasons in the 1980s.
Measurements: The HMO's costs for providing medical care and conducting vaccination programs were estimated using accounting data.
Results: 32% of high-risk elderly persons and 22% of non-high-risk elderly persons received influenza vaccinations. Aggregate vaccine effectiveness in preventing pneumonia and influenza hospitalizations was 30% (95% CI, 17% to 42%) for high-risk and 40% (CI, 1% to 64%) for non-high-risk elderly persons. The net savings to the HMO per vaccination was $6.11 for high-risk elderly persons and $1.10 for all elderly persons. The HMO incurred a net cost of $4.82 per vaccination for non-high-risk elderly persons.
Conclusions: Influenza vaccination rates in this HMO were relatively low for high-risk elderly persons. The medical care costs saved by preventing pneumonia and influenza through vaccination of high-risk elderly persons provide a compelling rationale to increase compliance with recommendations for annual influenza vaccination. Indirect benefits, such as prevention of suffering, incapacity, and lost wages, are likely to compensate for the small net cost of vaccinating non-high-risk elderly persons.
Author and Article Information
From Kaiser Permanente Center for Health Research, Portland, Oregon; University of Rochester, Rochester, New York; and the Centers for Disease Control and Prevention, Atlanta, Georgia.
ACADEMIA AND CLINIC
Influenza Vaccination Programs for Elderly Persons: Cost-effectiveness in a Health Maintenance Organization
Requests for Reprints: John P. Mullooly, PhD, Kaiser Permanente Center for Health Research, 3800 North Kaiser Center Drive, Portland, OR 97227-1098.
Grant Support: In part by the Centers for Disease Control Contract 200-89-0748.
This article has been cited by other articles:
|
|
 |
|
  P. Durando, D. Fenoglio, A. Boschini, F. Ansaldi, G. Icardi, L. Sticchi, A. Renzoni, P. Fabbri, A. Ferrera, A. Parodi, et al. Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults Clin. Vaccine Immunol., February 1, 2008; 15(2): 253 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Schaffner, S. J. Rehm, and T. A. Elasy Influenza Vaccination: An Unmet Need in Patients With Diabetes Clin. Diabetes, October 1, 2007; 25(4): 145 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Galvani, T. C. Reluga, and G. B. Chapman Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum PNAS, March 27, 2007; 104(13): 5692 - 5697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Spaude, E. Abrutyn, C. Kirchner, A. Kim, J. Daley, and D. N. Fisman Influenza Vaccination and Risk of Mortality Among Adults Hospitalized With Community-Acquired Pneumonia Arch Intern Med, January 8, 2007; 167(1): 53 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wolfe, K. Michaud, and E. F. Chakravarty Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders Rheumatology, November 1, 2006; 45(11): 1370 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. G. Voordouw, M. C. J. M. Sturkenboom, J. P. Dieleman, T. Stijnen, J. van der Lei, and B. H. C. Stricker Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia. Arch Intern Med, October 9, 2006; 166(18): 1980 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A Jackson, M. L Jackson, J. C Nelson, K. M Neuzil, and N. S Weiss Evidence of bias in estimates of influenza vaccine effectiveness in seniors Int. J. Epidemiol., April 1, 2006; 35(2): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kelly, T. Vu, and D. Smith Influenza Vaccination and Mortality in the United States Arch Intern Med, September 26, 2005; 165(17): 2037 - 2038. [Full Text] [PDF]
|
|
|
|
|
|
B. Christenson, J. Hedlund, P. Lundbergh, and A. Ortqvist Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Eur. Respir. J., March 1, 2004; 23(3): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Madjid, M. Naghavi, S. Litovsky, and S. W. Casscells Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies Circulation, December 2, 2003; 108(22): 2730 - 2736. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Telford and A. Rogers What influences elderly peoples' decisions about whether to accept the influenza vaccination? A qualitative study Health Educ. Res., December 1, 2003; 18(6): 743 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly N. Engl. J. Med., April 3, 2003; 348(14): 1322 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Oliveira, B. Lee, and G. L. Colice Influenza in the Intensive Care Unit J Intensive Care Med, March 1, 2003; 18(2): 80 - 91. [Abstract] [PDF]
|
|
|
|
|
|
D. W. Bratzler, P. M. Houck, H. Jiang, W. Nsa, C. Shook, L. Moore, and L. Red Failure to Vaccinate Medicare Inpatients: A Missed Opportunity Arch Intern Med, November 11, 2002; 162(20): 2349 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. McElhaney Guest Editorial: Influenza: A Preventable Lethal Disease J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M627 - 628. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ahmed, E. E. Elbasha, B. L. Thompson, J. R. Harris, and V.-P. Sneller Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination Med Decis Making, October 1, 2002; 22(5_suppl): S58 - S66. [Abstract] [PDF]
|
|
|
|
 |
|
 K. A. Poehling, M. R. Griffin, R. S. Dittus, Y.-W. Tang, K. Holland, H. Li, and K. M. Edwards Bedside Diagnosis of Influenzavirus Infections in Hospitalized Children Pediatrics, July 1, 2002; 110(1): 83 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Goronzy, J. W. Fulbright, C. S. Crowson, G. A. Poland, W. M. O'Fallon, and C. M. Weyand Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals J. Virol., December 15, 2001; 75(24): 12182 - 12187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Schneider, P. D. Cleary, A. M. Zaslavsky, and A. M. Epstein Racial Disparity in Influenza Vaccination: Does Managed Care Narrow the Gap Between African Americans and Whites? JAMA, September 26, 2001; 286(12): 1455 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ortqvist Pneumococcal vaccination: current and future issues Eur. Respir. J., July 1, 2001; 18(1): 184 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Oliveira, P. E. Marik, and G. Colice Influenza Pneumonia : A Descriptive Study Chest, June 1, 2001; 119(6): 1717 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weaver, J. Krieger, J. Castorina, M. Walls, and S. Ciske Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines Arch Intern Med, January 8, 2001; 161(1): 111 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Schabas Mass influenza vaccination in Ontario: a sensible move Can. Med. Assoc. J., January 1, 2001; 164(1): 36 - 37. [Full Text] [PDF]
|
|
|
|
|
|
A. Cifu and W. Levinson Influenza JAMA, December 13, 2000; 284(22): 2847 - 2849. [Full Text] [PDF]
|
|
|
|
|
|
C. B. Bridges, W. W. Thompson, M. I. Meltzer, G. R. Reeve, W. J. Talamonti, N. J. Cox, H. A. Lilac, H. Hall, A. Klimov, and K. Fukuda Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial JAMA, October 4, 2000; 284(13): 1655 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lawson, V. Baker, D. Au, and J. E. McElhaney Standing Orders for Influenza Vaccination Increased Vaccination Rates in Inpatient Settings Compared With Community Rates J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2000; 55(9): 522M - 526. [Abstract] [Full Text]
|
|
|
|
|
|
G. A. Poland and R. Couch Intranasal Influenza Vaccine: Adding to the Armamentarium for Influenza Control JAMA, July 14, 1999; 282(2): 182 - 184. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wilde, J. A. McMillan, J. Serwint, J. Butta, M. A. O'Riordan, and M. C. Steinhoff Effectiveness of Influenza Vaccine in Health Care Professionals: A Randomized Trial JAMA, March 10, 1999; 281(10): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Nichol, L. Baken, and A. Nelson Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease Ann Intern Med, March 2, 1999; 130(5): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Nichol, J. Wuorenma, and T. von Sternberg Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens Arch Intern Med, September 14, 1998; 158(16): 1769 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Diguiseppi Why everyone over 65 deserves influenza vaccine BMJ, November 9, 1996; 313(7066): 1162 - 1162. [Full Text]
|
|
|
|
|
|
R. D Elon Recent Advances: Geriatric Medicine BMJ, March 2, 1996; 312(7030): 561 - 563. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Small, B. S. Bender, F. Carrat, T. B. McCall, K. L. Nichol, and K. L. Margolis Vaccination against Influenza in Healthy Adults N. Engl. J. Med., February 8, 1996; 334(6): 402 - 404. [Full Text]
|
|
|
|
|
|
K. L. Nichol, A. Lind, K. L. Margolis, M. Murdoch, R. McFadden, M. Hauge, S. Magnan, and M. Drake The Effectiveness of Vaccination against Influenza in Healthy, Working Adults N. Engl. J. Med., October 5, 1995; 333(14): 889 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Patriarca and R. A. Strikas Influenza Vaccine for Healthy Adults? N. Engl. J. Med., October 5, 1995; 333(14): 933 - 934. [Full Text]
|
|
Article
